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. . The grcntcst a p p l i c a t l n n w w  
. . prove to be in t h a e l d  of n iune, in which tlie progression 
of c ~ g l e  organ system. Under t ime  
circumstances the provision of good renal or hepatic or cardiac f~inction 
might be expected to restore normill health. In adult patients comparable 
lxoI)Icms iirc* frc~c~~lc!ntly i ntl somc:timcls rincxprctcclly co~nplicatc*d I)y 
disorders other thi~n those to which treatment was originally directed; 
examples ilre known of myocardial infarction, stroke or even ~nalignancy 
in older patients who had been w~cc~ssfully treated with renal homo- 
transplantation. 
In this communication an attempt will be made to define the poten- 
tial usefulness of homografting procedures in infants and children, , 
excluding cases of identical twins. Although experience in all age groups 
and in laboratory animals will be alluded to, the principal emphasis will 
be directed to the medical, technical, psychologic and sociologic prol)- 
lems cncor~rltercd in trci~ting ii sericts of patic!nts at or I)c-low the iigc 
of 18 years. Discr~ssioli will 1)c limitc!d to tri~rispI:itltatio~~ of thc: kidney 
and thc livcr. Succcss with thc former orgall has alrc*ncly I)ccn iichicvcd 
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to a previously unhoped-for degree. Findings in the laboratory suggest 
that comparable results are at least theoretically attainable with the liver. 
RENAL TRANSPLANTATION 
During tlie last three ycirs 22 pediatric patients were treated at the 
University of Colorado Medical Center with lio~notransplantation of the 
kidney (Table 9). Seven were 12 years or younger at the time of opera- 
tion, and 15 were from 13 to 18 years. The original renal disease was 
chronic glomenllonephritis in 18 cases, polycystic disease in one and 
end-stage pyelonephritis in the other three. The life expectancy without 
either dialysis or homotransplantation was only a few days or weeks in 
each instance except one. Most of the pittients had had a chronic debili- . 
tatirlg ill~wss, but ill tlic r~rinority cli~tiwlly evident sy~npto~ns Irad been 
present for only a few months. In all but one case, resuscitation with 
the artificial kidney was necessary before transplantation could be con- 
sidered; the greatest number of preoperative hemodialyses was 35 
(patient LD 1 ). 
Donor Selection 
All 22 patients received kidneys from living volunteer donors. For 
reasons discussed below, familial donors were considered to be the most 
suitable, particularly at the time of treatment of the first 16 patients 
when llistocompatibility matching was not being done. Principally be- 
cirllse of tllct young itgc of the rccipic*lits,   no st of thc kidnays ( 18 in all) 
were obtai~ied from pare~lts. One each was from a sister, aunt or uncle. 
Two homografts were from nonrelatives (Table 9). Two homografts I 
were used in case LD 19. Tlie first one, obtained from the mother, failed 
acutely, presoma1)ly 1)ccausc of a donor-recipicl~t blood group incom- 
patibiiity, and was removed immediately. A second kidney from an unre- 
lated donor was placed two weeks later; in the summary statistics only 
the second or definitive donor is considered further. 
The role of dorlor iind recipient I)lcw<l grollps in determining the 
trdvisul~ility of t ru l~~l ) l i~~t t i~ t io~~ is i 11 il ~portir~rt o ~ ~ c .  I t  is now rccog- 
uixed'** that tissue transfer between donors and recipie~~ts of differ- 
ent blood types shotild conform to the general rules which apply for 
unmatched blood transfusions (Tahle 10). Early in our experience this 
scheme was violated on four OC~PS~OIIS, includi~lg two of the pediatric 
cases in tlie present report. Two homografts of A and B type respectively 
failed i~nmediately ill 0 rcvipients, apparently owing to binding of host 
isoagglutini~is to the red cell antigens which are known to be present in 
. , 
renal tissue.'". 18. In a third case ( A  to 0) the liomograft functioned .- ..  .  
well (Fig. 23) for 202 days, until the recipient's death from nonrenal 
i 
! 
Table 9. Pediatric Patients Treated witlr Renal Homografts 
at the Uniunsily o f  Colorado Medical Centn 
I n  dl rurr  rhr hduj r  ww8 .Ih"udd/rem mdul&w deurr. Swmd i r  1. Nrmr*n 24, 1W T7h rr,uiuu c L u u r r  
(&). U d  w e  mlrogan Irluls (BUN), b l d  prarrurrj ( B P )  4nd p*dn~reu do181 418 Lkrr m Orrobrr and Nwnb,r, 19%. 
d i l l  & 6 #J h a 8  p&nU ham b88n p n r e u d ~  r8pwld win# rk run8 d# n u n k r ~  
O U U -  DO*O. 
uvtno nw n.o l~-  01w P*SI,UI. 
DATaU. 0 1  IUa- I.YT DOnUa nAL UIl Y~na 
Tun*  Dam VIVAL aL000 LEU- 01s- (mi./ (m8. 
ID no. AD. lax r u w r  11/24/65 ( D A ~ )  mu mon a*u mio.) mun m r  r.a BAY) 
I .  I2 M 11/24/62 Livlng 1036 B+ toB+ Motbcr CCN 96 19 104/60 U 
13" 15 M 7/3/63 Living 875 A+ toA+ Mother CON 100 17 110/70 7.5 
17 I5 F 7/19/63 Living 849 0- t o o +  Mothcr CPN 64 11 130/70 2.5 
l e  Kidney removed 
I9 17 M 7/26/63 7/26/63 - A + t o O + M n t h e r  CPN - - - - 
2nd 
8/9/63 h a d  95 O+ t o o +  Urue1.M - - - - - 
20 6 M 7/29/63 Dud 202 A -  t o o +  Muthcr CON - - - - 
22.. 15 F 8/12/63 Living 835 O +  to O+ Muther Pdycyatic 89 24 134/16 10 
26 16 F 8/29/63 Dead 2/3dmy A + tu A+ Fatlur CON - - - - 
33 18 F 10/7/63 L~viny 779 A+ tu A+ htutllcr CON 110 14 IZU/86 0 
34 8 P 10/11/63 Livtrq 775 O + t u O + M u t l l a  CON 89 14 lW/68 U 
39 17 M 11/13/63 Living 742 0- t o o -  Mother CON 87 20 130/80 1.5 
41'. 3 M 11/23/63 Livtns 732 A+ toA+ Motbcr CON 36 28 110/82*.* 7.5 
SO*' 16 F 1/25/64 Living 669 A+ IDA+ Fatha CON 96 20 120/92*** 7.5 
M a t 4  
51 I8 M 2/10/64 Living 653 O +  t o o +  aunt CCN 104 18 IZO/M)*** 10 
52 15 F 2/17/64 Living 646 O + t o O +  Father CON 85 2 3  140/70*'* 7.5 
Materml 
53 15 M 2/22/64 Living 641 O+ t o o +  uncle CGN 96 20 130/90*" 10 
61 5 F 3/23/64 Dead 36 O +  to O +  Motbcr CON - - - - 
75 18 M 2/19/65 Living 278 A+ toA+ Father CPN 87.6 36 140/80*** 25 
79 16 M 3/23/65 Living 246 A + l o A +  Mothu  CON 24 50 110180*** 40 
80 10 hf 3/29/65 Living 240 O +  t o o +  Und. M W N  7 0  17 118/90*'* I5 
85 18 M 4/23/65 Living 215 O +  t o o +  Surer CON 80 21 130/8O*** 30 
90 18 F 7/23/65 Livi.8 124 O +  to A+ Mother CCN 74 30 130/80*** 30 
93' 8 F 8/6/65 Living 110 AIM- to Motbcr OCN 44 25. 100/70*** 25 
A*B+ 
.TIIV~~TIOIII~ hclurr trnrupla~itrnt~un. 
... ~'II~III~VI~~IIV fr811l1 111 III 16% IIIUIIIIIV after ~tm~~uplnn~ut~un. 
*** R a c t v ~ r r ~  ltt~l~ypcrtcnslvr 'lruqs (EIIIIPIIIIII~U~C, llydrrlrllne, reurplne ur ~ l ~ c t l ~ y l  DOPA) 
causes (LD 20, Table 9). A fourth patient, an adult of A blood group 
who received a kidney from his B type sister, is in good health more than 
2% years after operation with excellent renal function. Thus the principal 
risk with the use of the unacceptable donor-recipient blood type in- 
compatibilities seems to be an acute one due to an immunologic reaction 
that may be distinct from that of rejection. Although such tissue com- 
binations should not be used in the future because of the danger of 
immediate failure, it is pertinent in considering the role of red cell 
Table 10. Dircclion o f  Acce~rable Afismatchcd Tissuc Transfer* 
- 
O t o n o n - 0  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Safe 
RH- to RH+ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  S d e  
RH + to RH - ... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Relatively safe 
A to non-A.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  .Dangerous 
Btonon-B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Dangerous 
AB to non-AB.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  Dar~grxour 
0 ir u n i v d  donor; AB u u n i v c d  r+pient. 
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the necessary ischemia times have been longer in our hands, a factor 
which has a proved adverse effect upon early function.'" The consequent 
extra risk of failure is not thought to be j'ustsed if a living donor is 
involved. 
His tocompatibility Tests 
One of the most pressing needs in the field of clinical homotrans- 
plantation is the development of accurate and practical methods for 
preoperative detection of histocompatibility, since the vigor and perse- 
verance of the subsequent rejection are related to the degree of genetic 
dissimilarity between the donor and recipient4% It  is undoubtedly for 
this reason that the best results in our total experience in all age groupsa1 
and in the collected world statistics8@ have been with the use of familial 
donors; here the mathematical possibility of fortuitous histocompatibility 
matching is increased4' Nevertheless crushing rejection has been en- 
countered after intrafamilial homotransplantation, emphasizing that not 
all related donors are suitable. Conversely, smooth and uninterrupted 
recovery has been observed in some patients after homotransplantation 
of nonrelated kidneys. It  is evident that there is a spectrum of donor 
suitability for the individual recipient in both the related and nonrelated 
populations. Eventually, it is to be hoped that the favorable and unfavor- 
able donors can be distinguished with the antigen matching methods now 
being developed in a number of laboratories. Progress in this field was 
recently summarized in the proceedings of a National Academy of Sci- 
ence Seminar held in June, 1964.'' 
Until now the development of tissue matching techniques has been 
hampered in man by the absence of knowledge about the number, loca- 
tion and strength of human histocompatibility antigens. Terasaki, at the 
University of California in Los Angeles, has attempted to obtain this kind 
of information by retrospective study of chronically surviving recipients 
and their donors from the Denver,"' Bostonaa and UCLA series. His 
method involves the use of a panel of different cytotoxic antiserums 
obtained from presensitized plasma donorse1 which differentially destroy 
tested lymphocytes according to their antigen content. In his initial 
studies Terasaki found the correlation between the clinical course and 
the donor-recipient antigen matches to be irregular and incomplete. 
Nevertheless the best results tended to be in those patients who had the 
greatest antigen similarity to their donors.81 
Because of these suggestive findings, a prospective study was under- 
taken in October, 1904, in which all donors for new cases were selected 
partly upon the basis of their antigen match with the recipient. Included 
were the last six patients in the presently reported series. Since the insti- 
tution of this screening program, uncontrollable rejection has not been 
observed, but the length of follow-up is still too short to permit the 
conclusion that the method is of value. All six pediatric patients with 
Terasaki-selected donors are still alive, from 3% to nine months post- 
operatively. 
The Ethical Issues 
The ethical and social problems accompanying clinical research 
in the field of homotransplantation have been the subject of editorial 
comment by Elk in t~n ,~  Robin4& and other prominent members of the 
scientific community. At the time the opinions of most of these authors 
were expressed, it was not generally known that the results after clinical 
homotransplantation had already undergone a remarkable improvement. 
It was, therefore, reasonable to question the propriety of applying a form 
of therapy which stkmed foredoomed to early failure. Unfortunately, 
the recognition that transplantation can offer significant prolongation of 
life to the uremic patient has not eliminated the moral issues which must 
be faced today, particularly in formulilting policy for treatment of pedi- 
atric patients. 
As discussed above, the use of living donors incrcases the chance of 
success, since optimally preserved tissue can be ensured under controlled 
circumstances. Moreover, the use of kidneys from blood relatives im- 
proves the outlook, since the probability is greater of obtaining a good 
donor-recipient histocompatibility match. Tllus the best donor, short of 
an identical twin, is most likely to be a parent or a sibling who has 
reached the age permitting legal consent ( 21 years ). Performance of 
homotransplantation under these circumstances provides the best prog- 
nosis for the recipient. It also carries a medical risk, however small, for 
the donor, and it introduces the possibility that a donor may be selected 
on the basis of presumed expendability by familicil arbitration and 
coercion. Transplantation under less optimum conditions, such as witb 
the use of unrelated volunteer donors, reduces the chance of recipient 
survival.8g* Traditional morality would seem to be best served with 
the use of cadaveric organs, if one excludes from consideration the pros- 
pective recipient whose chances of living are thereby further reduced. 
Even the use of cadaveric organs is not free of onus; the right of a dying 
prospective cadnvcric donor to receive the full measure of available 
therapy must be protected without regard for the events that are ex- 
pected to follow after death. 
These and other matters have, of course, occupied the attention of 
all groups working in this field. Before undertaking the care of children 
or infants, additional factors must be considered as described by Riley.'' 
These include preoperative evaluation of the effect of such an under- 
taking on family unity, and upon the mental health of siblings. Perhaps 
the greatest doubt of all is posed by the fact that the ultimi~te prognosis 
is not yet known in that group of survivors IIOW living, in apparent good 
health, 1% to three years after operation. I f  their homogrnfts gradually 
fail during the next five or 10 years, will the benefits be compnrrble to 
those in the vocationally trained adult for whom such an interim of 
borrowed time could mean a return to work and pre-existing social 
responsibility? Woodruff60 has reminded us that it is not our task to 
confer immortality. One might also wonder whether any man has the 
wisdom to adjudicate the relative value of another's years, even those of 
a child. 
Preservation of Tissue 
Whether the homograft is from a living donor or from a cadaver, 
it is subjected to a variable period of ischemia. The easiest means of 
millimizing the anoxic injury is organ cooling. Kidneys obtained from 
volunteer donors are perfused immediately after removal with cold 
lactated Ringer's solution containing 50 mg. of heparin and 1 Gm. of 
procaine chloride per liter (Fig. 24). In dogs this simple expedient 
provides good protection of the autografted kidney during devasculari- 
zution for one or morc hoors. The d~~r i~ t ion  of permissible total ischemiu 
for the llomograft is probably not us long us this for reusons discussed 
elsewhere.'* From practical experience it has been learned that prompt 
15°C lactated Rinqcz~ii 
with 50mqn1 heparin 
and 1 qram procaine 
I per liter , 
140 cms Hz0 
Figure 24. Technique of perfu- 
sion of kidneys with cold lactuterl 
Hinger's solution. Without the addition 
of procuil~e, great difficulty may be en- 
countered ill obtnining su5cient flow, 
possibly owing to afferent arteriolar 
constriction. Usually only 200 to 500 
cc. h required to cool the orpun to 
15 to 20.C. ( By per~nission of Surgery, 
55: 195,1964.) 
renal f~lnction of the 11uma11 homograft can be expected if the kidney 
is cooled I)y this ~nethotl atrtl .r~vasculi~rizccl in tht: host within 40 
min~tes .~"  Urine rxcretion may' occur after much longer periods of 
iscllernia, but reliu1)ility of early function is progressively reduced with 
greater i~ltcrvuls o f  tissrlc irnoxia. 
Cooling of the 1)ost)nortem Ilomograft is also of pura~nount im- I 
portance. Using variorls methods of cold perfusion or simple cooling, ! 
D ~ n e a , ~  Ma~Leiin, '~ Hume,'O Hamburgerl%nd hlowbrayY have all 
recently had improved results with cadaveric kidneys. Although prompt 1 
renal function was oftcan not ol)tained as the consequence of acute tu1)u- 
jar necrosis, skillf111 post-transplaat dialysis care was used to maintain 
the recipient patients nntil the ischemic injury had healed. It is probable 
that the ideal candidate for cadaveric transplantation is a patient who 
has already entercrd ,urltl I)c~c!n stal)ilizcd on a chronic diillysis program. 
If the cadaveric kidney docs riot fiulction properly at first, the previous 
care with the artificial kidney can be continued for some days or even 
weeks until the diuni~ged organ I)egins to excrete utlequate ql~ilntities of 
uriue. As discussed below, special precautioi~s with immunosupl~ressive 
drugs are necessary ill such patients with delayed or poor initial function. 
[. The methods of cooli~rg, though valuable, allow only short-term ; 
preservation. In the future, perfusion techniques will probably be de- 
veloped which will permit storiige for much longer periods of time. 
The value of hypothermia in coml)ini~tion with extracorporeal whole or 
, 
partial cadaver perfusion has already been demonstrated,gu. 32 using 
a co~nmercial heart-lnng apparatus to provide an artificial postmortem 
circulation. Perfusio~~ of si~lglc! organs is Inorc! difficult,' but if such 
methods become practical, they will make possi1)le the establishment of 
banks for which vital organs could \)e re~noved from cadavers, have their I 
function evaluatecl in the extracor!>oreul state, and 1)e used for elective 
operations. 
Technical Problems 
Detailed descriptions of the donor operation are a ~ a i l a b l e . ~ ~  4 u  To 
date there have been no rctported t l l ~ i ~ t h ~  in living volunteers. The high 
degree of safety with which ~~ephrc*r.tomy can l)c carried o t ~ t  is l>rol)i~bly 
ascril)al)lc: to two factors. First, the removal of ;I ~rorrn;~l kidney is not 
ordinarily diffic~~lt. Second, these operatio~ls ]lave I)een pcrforrned with 
ideal exposure and with unusuiilly great cilrc. None of the living donors 
at tllr U~~iversity of Colorado Medical Center has required blood trans- 
fusion. 
All the 22 recipie~lt pirtients i l l  thc present series also hiid removal 
of their splecr~ i ~ i l ~ l  diseased kitlnevs. TIlc splcoectomy and nt:phrectomies 
were performed at the same tilnc! ;IS the transplnntatio~~, except in two 
cases. 
Special problems may be encountered in homotransplantation to 
I recipielrts of yorll~g age i f  adult kidacys ilre used. For almost all children 
12 years or oltli.r, tlre standi~rtl extri~l)r.rito~lenl operation of, KiissX4* is 
satisfactory. After removal, the kidney is r~s~lirlly placed in the opposite 
iliac fossa of the rccipiellt, t11ercl)y reversing the 11orma1 anteroposterior 
rclutiolrs of tllc llilirr structures (Fig. 2 5 ) .  111 its new position the pelvis 
i111d ureter are anterior, the re11;il artery is intermediate, and the renal 
veil] posterior. The renal artery is attacl~ed to the hypogastric artery and 
the renal vein to the side of the external iliac vein. The ureter is implanted 
directly illto tile I~laddrr by a nipple i~nd  tunnel technique (Fig. 25), 
or i~ttachetl with i111 end-to-end ani~ston~osis to the distal portion of the 
recipient ureter; alternatively, uretcropelvic anastomosis may be used. 
The preoperiitively placed Foley catheter is removed in 21 hours. 
Internill splints or catheters are not used. 
Figure 25. Usual ll~etllocl of re~lal transpluntation. The opposite donor kidney is 
rc:vi~sc~tlarized in t l ~ e  extraperitoneal space with a hypogastric to renal arterial anasto- 
I I IOSI~ ,  u11d with an end-to-side connectroll c ~ f  the renal to external iliac veins. A uretero- 
nei~ystostomy as shown prov~drs siltisfactory urlnnry drainage. ~lternetiveiy, a ure- 
terolrreterostomy or ureteropyelortol~~y nluy be performed. ( B y  permission of J.A.M.A., 
187:734. 1964.) 
In children under 12 in wllorn tlic iliac fossa may be too small for 
accommodation of an adult kidney, a transperitoneal 6peration is ad- 
visaLIeS6 through a total midline incision (Fig. 26, insert). The right 
colon is reflected to the left, and the renal vessels are anastomosed end- 
to-side to the aorta or vena cava or to the common iliac vessels (Fig. 26). 
Six of the 22 children in the present sericss h i~d  this operation. There were 
no  technical fiiilurc:~. I3c:cuusc of tho s~nnll size of thc rccipicnt, the 
length of homograft ureter necessary to reach the I~ladder or to reach 
the distal portion of the recipient ureter is not increased. Since the vas- 
cular anastomoses are n ~ a d c  as large as will ever be required, there 
should be no problem of late anastomotic stenosis due to recipient 
growth. 
Adult homografts hive heen used in recipients as young as three 
years. There have s,cemetl to be no pllysiologic problerns with the use of 
such a disproportionately large orgon homograft. Heart failure was not 
observed. One of the cilildren liatl intestinal obstruction from an adhesive 
band at the site of the right colonic reflection, which was easily treated 
Senteuy cut to 3how 
ant auuface of 
Cut to  how undou- 
Figure 26. Metlrod for traiisplo~rtntion of u ~ i  uilult kidney to u child rcw~pierit. 
f l i t ,  operation is done trunslw~itoncnlly t l ~ r o ~ ~ g l i  a co111l)lete midlirre i~icisiori ( ituert). 
The asc~uding COIOII is reflected to the lcft, irlltl tlre re~rul nrtery ulrtl vein are unas- 
tornosed to the great vessels of the r r c ~ o i c ~ ~ t  us clr1)ictcd. (By  pen~ltssiori of Surg., Cynec. 
& OLst., 119: 106, 1cJ&I. ) 
at a secondary operation. Four of the six children operated upon with 
this technique are still alive after 3% to 25% months. 
General Postoperative Care 
If a well functioning homograft is placed, the problems of fluid and 
electrolyte management may be exaggerated in the infant or young 
child. Massive diureses have been observed of as much as 2000 rnl. per 
hour. The electrolyte composition of the urine at this time is usually 
about 100 mEq. of sodium, 70 mEq. of chloride and 15 mEq. of potas- 
s i ~ m . ~ ~  Serious errors of fluid therapy can be introduced, however, unless 
repeated plasma and urine electrolyte determinations are carried out. 
One of the deaths in the present series (LD 26) occurred as a result of 
an acute electrolyte disorder during the first postoperative day. Iatro- 
genically induced hyponatremia and hyperkalemia were followed by 
cardiac arrest. 
The acute post-transplant diuresis usually runs its course within 
24 to 48 hours. During this time one patient (LD 17) lost more than 
30 pounds. A remarkable improvement in their general medical conditio~l 
occurs during this time. The patients usually have a much more rapid 
early convalescence than their donors. Unless contraindicated, diet is 
resumed on the morning after operation and ambulation started that 
evening. 
Immunosuppression 
Although the above-described technical and general medical details 
of care are of the utmost importance, the unique problem of transplanta- 
tion surgery is the prevention of homograft repudiation by the host. 
If aggressive measures are not taken, the good early function which 
follows operation ceases within a few days or weeks in all but the excep- 
tional case. Since there is at present no highly specific form of therapy, 
consistent success depends upon the combined use of several therapeutic 
adjuncts. These include the drugs azathioprine, actinomycin C 'and 
prednisone. Local homograft irradiation or total body irradiation has also 
had wide clinical use. 
In most centers the most useful pharmacologic agent has been 
azathi~prine,~ a cytotoxic drug which interferes with nucleic acid syn- 
thesis.2. "erapy is started at the time of or frequently several days in 
advance of homotransplantation. In all cases it has been continued in- 
definitely thereafter. An immunosuppressive effect is observed without 
suppression of the white cell count to dangerous levels, and, indeed, the 
accidental production of leukopenia has been the most common cause of 
early failure. The appropriate daily dose of the drug is variable, ranging 
from 1 to 6 mg. per kilogram, and is adjusted according to the white 
blood cell counts. Since azathioprine has a partial renal pathway of 
Imuran. B ~ m u g l r s  Wellm~ne & Co., Inc.. 1 Scandale Road. Tuckithoe. New 
York. 
detoxification,' the dose should be reduced in the event of the secondary 
renal failure which may accompany a severe rejection episode. Simi- 
larly, if a kidney is transplanted which fails to function properly at the 
outset, as is often the case with cndaveric hotnografts, doses should be 
prescribed which are considerably smaller than in the usual case. 
In spite of its usefulness in clinical homotransplantation, azathioprine 
alone does not usually prevent an acute rejection episode. In our earlier 
I experience in which pharmacologic agents were added serially to the 
therapeutic regimen, only two of 45 patients escaped rejection. In this 
series the use of prednisone in large doses added at the time of acute 
I postoperative homograft failure seemed to be lifesaving (Fig. 27). Be- 
1 cause of this almost invariable sequence of events and because it was 
I later obser~ed*~ that prophylactic steroids in large doses often reduced 
the severity or even prevented early rejection, we now use prednisone 
I from the time of operation, usually in doses of 0.5 to 1 mg. per kilogram, 
I until the onset of clinical rejection. At that time the dose is increased 
I I to 2 to 8 mg. per kilogram. 
Two other adjuncts are of value at the peak of a rejection crisis. 
I Actinomycin C, which was demonstrated by Calne and his associates2 
to cnltsc rc!vrrsnI of rc.jc.ctinrb in nnim;ils, is givcn c:vcry four or five dnys 
in doscs of 200 t o  40() rnicrogrnms (Fig. 20). 1.ocul hornogriift irrudintion 
is administered in three doses as described by Kai~ffmann,~~ using 150 R 
at depth on each occasion. 
The use of total body irradiation in American clinics has been largely 
abandoned because of the high mortality' rate from complications, par- 
ticularly sepsis. Hamburger". 16 in Paris has, however, continued to use 
total body ionizing irradiation with excellent results. Only one patient 
in the Colorado series received total body irradiation ( LD 1 ). His white 
cell count was depressed to approximately 500 for almost two weeks 
after operation, and after recovery from this episode he was converted 
to Imuran and steroid therapy (Fig. 28). 
Clinical Features of Rejection in Patients Receiving Immunosuppression 
The diagnosis of post-transplant rejection depends upon multiple 
clinical obse~ations.~** 4g Its features are most easily recognized in pa- 
tients who have had good initial homograft function and are receiving 
treatment with azathioprine alone. Undcr such circumstances a secondary 
decline of renal excretion is almost certain evidence of rejection, particu- 
' larly if a systemic febrile illness is present concomitantly. A classic exam- 
ple is shown in Figure 27. The patient, who received a kidney from her 
.' mother, had excellent function for the first postoperative week. At that 
time there was a decline in creatinine clearance, a secondary rise in 
blood urea nitrogen level, proteinuria, a tendency to hypertension, and 
fluid retention. She complained of tenderness over the transplant wound 
and had a fever in excess of 3g°C. The addition of large doses of 
prednisone and intermittent intravenous administration of actinomycin C 
to the basic therapy with azathioprine resulted in reversal of these 
findings. If prompt improvement is not noted in such cases, local homograft 
irradiation is applied immediately. 
Although the reversal of rejection is a phenomenon of great impor- 
tance in making clinical transplantation a practical undertaking, an 
additional feature is equally noteworthy. After reversal has been ac- 
complished, the intensity of immunosuppressive therapy is ordinarily 
less than that required for control of the initial crisis. It is improbable 
that many patients could live for protracted periods of time if the aggres- 
sive therapy required early had to be extended into the later course. In 
actuality, it is usually possible to begin withdrawal of steroids within 
the next few days or weeks. The patient illustrated in Figure 27 had 
steroids discontinued altogether after one year. During the subsequent 
year she has received only azathioprine, the drug which initially did not 
prevent the onset of a relatively severe rejection. Her homograft biopsy 
23 months after operation was normal except for a small i1m011nt of 
subcapsular scarring. 
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Late Rejection 
Although there is ill1 irlcrc~asc~tl c . i . ! ~ r c * ~ ~ t  o f  si?cirrity wit11 the passage 
of time, thc threat of late rc~jc!qtio~i 111o1it1is or ( n ~ c : ~ l  ycvrrs itfter ho~no- 
transplitntatiorr is i~ sig~lificar~t or~c.~", I f i s  " 6  111 tllc! total scricss of Colo- 
rado cikses, i~lcI\idilrg i ~ t l ~ l l t ~ ,  12 c,xi~rnl)lcs of t1c:liiycd rc.jcctiol~ have I)cen 
observed, three in tlie pediatric series herein reported (1,D 10, 22, 41). 
Invariably, these have seenlcd to I)e precipitirtetl by tire withdrawal or 
reduction in dose of pretlnisone (Fig. 29). Although this complication 
was partially revorsil)lc, tliirrc w;u solnc pcr~nii~lc~rlt loss of renal frtrlctiotr 
in rnost i~rstances. Tlre tliscrrntinuiuicc of prc.cl~risonc or even its redtlc- 
tion to doses below 0.5 to 1 rng. pcr kilogram must tl~errfore l)t! done 
with caution and with careful wec4ily re-evalrration of ri.1iitl frrnctio~~. 
The most useful indicittor of latct rcjcctio~~ has 1)een tht: crcSiitir~ir~c cl ;lr- 
ance, which rnay slo\uly dcclir~c for sor~ic clays or weeks I)c-fort. c.lcvatic*n.: 
in blood urea nitrogcr~ arc ol)scrvcd. W ~ I ~ I I  Jotc rcjootio~r is diirenosetl 
the o ~ d y  effective form of t11crit~)y is intensification of the irnrnirnosrrr~ 
pressive regimen, the most ilnportirnt stcp I~cing to iucrease the prc.d~ri- 
sone dose. 
One of the four r~rlsr~ccc*ssfrrlly trei~ted putic*rrts ( 1 .D 26) i l l  the 
present series died o f  ucute electrolyte* iml)i~lit~~r.e cl~irir~g tlie posto1)eru- 
tive iliuresis. Another ( I,D SO) succrrinl)cd itftt~r 209 diiys ( Fig. 20)  of a 
central riervoc~s systtbnr t1iscrrtlc.l. of I I I I ~ I I O \ V I I  o r ig i~~ .  I ~ c ~ ~ ~ i l l  f ~ ~ ~ ) c . t  ioll I V ~ I S  
adecil~i~tc:. l'i~rmissio~i for a~rtopsy wits t l l ~ r ~ i c ~ t l .  'l'l~e ot11c.r two putic.1rts 
(LD 19, 61) tlic?tl :rt '3.5 a~rtl  fR clirys of ~~~~~~~~~~~~~ystis c.trriirii prleumo- 
nitis (Fig. 30) and L:. c.-oli scptici*rni;r. respectively; tlrc loilger survivor 
had satisfactory renal fiinction (Fig. 31 ), I)i~t he otllcr cl~iltl wits at the 
peak of o rejectior~ c.l)isode. Tlw cor~triI)~rtio~~ c)f ii~~~nr~rios~~~)l)rcssivc 
therally to deuths s~rch as the liittcr two I I ~ I S  I)ccl\ cliscr~ssetl ill detail 
e isewl~ere .~~ 
Late Azathioprine Toxicity 
Although sepsis durir~g tlre lrse o f  ~l~itxitr~al irnrnri~~osl~pprt.ssive 
therapy is the ri~ost eor~rr~loir fiitirl  cornpliciitio~~ csirrly i4ftt.r I~o~notrarls- 
plantotiorr, patierrts who s~rrvive Iri.yorld ti l l !  first fcw rl~or~ths 11irve sur- 
prisingly little s~~scel)til)ility to sigrlifica~~t i ~ ~ f c c t i o ~ ~ .  Ileilctivity to viirior~s 
test antigens is reduc.c~tl."', ux Nevcbrtht.Iess rlorle of the 18 s~trviviug 
pediatric ~)utic.nts has 1)c.i.11 tro~rlrl~d wit11 rcucirrrcrlt Iirtc infcc*tiorr. 
To date t l ~ c  pri~rc~lritl Iittc l)rol)li.r~r wit11 ;~zittliiol)ri~le Irirs 1)c.e11 
/rcpatotoxicit).. 111 (logs tl~is c l r i ~ s  11;1> 1 ) c 8 i * r r  S ~ I O \ V I I  to 1 ~ 6  ;I sig~rificitilt 
liver poiso~r which catrsc8s lrt!oirtic i~r j r t ry  \ v i t l i i r ~  i t  fc,w tlirvs i1ttc.r I)c.gi~~- 
I I I I I K  ; I ~ ~ I I I ~ I ~ I ~ ~ P ~ ~ I ~ I I . ~ ~ ~  'l'!rc: trig11 (lcbgrc*c  of toxic~itv is . ~ ~ ~ ~ ) a r l ~ i r t l v  \l)t~c.ii~s- 
Figure 30. l 'er~~iillvl pneull~onia wliich was s t ~ b s r q u e ~ ~ t l y  dell~onstrated at 
ii~~topsy to I)e due to Pr~eccitlocfptis corinii. Ilistolo~ic aviclence of cytomegalic inclusion 
tliseusc was illso prescrit. Tlle trunsplnntutio~~ wus currircl olct 011 J l~ ly  26. 1W3, ant1 tile 
patient diet1 of pu1111o11iiry i~~s t~ l f ic ie~~cy  011 Novrt~il,rr 12, 1U63. l'lie x-rity fill11 WIIS 
ol~tui~letl on November 11, 1963. Renal irlsrlfficirl~cy was not a factor in tile unfavorable 
outcome. 
specific for the dog, but four adults in our experience have suffered 
severe liver injury after months or years of azathioprine therapy; one 
of these patients died of a combination of liver failure and bacterial 
sepsis."' Thus far this has not been observed in patients of 18 years or 
less. Nevertheless periodic liver chemistry studies si~ould be obtained on 
all patients receiving this agent. 
Problems Peculiur to  the Pediatric Patient 
Although the young victims of terminal renal disease have proved 
to be exceptionally favorable candidates for homotransplantation, thev 
have unique problems in care. The technical difficulties and 
the coml)lexities of  early fluid and electrolyte management have already 
txen mentioned. An additional feature whicli deserves special emphasis 
is tlie postoperative tenrlency of the vorlng patient to bizarre periplieral 
I)lootl patterns, particr~larly normo1)lastemiir. .411 exi~ml)le is shown in 
Figrlre 23 of i1 five-year-old boy wllosc nucleated peripheral blood cell 
count of almost 50,000 co~lsistcd ot 40,UK) nor,mol)lasts. Failure to recog- 
'. 
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Figure 31. Course of ;III ur~s~~cr.rssful c;lsc! of rc*11i11 11o111otri11isp1i111ti1tion. 'I'llc 
initial holnogri~ft fuiled i ~ ~ ~ c ~ ~ c ~ l i i r t c l y  I)ec;~~~se of  a I)ltmd group il~coll~patibility; the 
mother was A I)locd type iu10 tl~e p i ~ t i r l ~ t  was 0. The tlcfilcitive I~ot~iogroft was fro111 
an unrelated donor of 0 1)lcx)d grotlp. Death cxc~~rrrri fmln pululol~i~ry i~~sr~fficiellcy 
caused by Pt~eu~noc.!ls!is cclri~lii p11e11111onia. 'I'lle pi~ticl~t's cl~cst x-ri~y is sl~owl) in Figure 
30. Note that renal fulcctiol~ was well l n i ~ i ~ ~ t i ~ i n e c l  ~ ~ u t i l  illst Iwforc tleath. 
nize the significance of this peculiar dilfcr~~~tiir l  cor~ld Icud to the ad- 
mini strati or^ of excessive amthiopri~lc (loses. An i l~~oc i i i t io~~  f this 
finding with polycythemia has I)een t1escril)ed I)y Nies.'" 
Therapy with predl~iso~ie is also it miittcr of i~icrensccl concern in 
the growir~g child. Tllc rcs r~ l t a~~t  ilcllc, wcigl~t rctlistril)utior~, cosmetic 
faciiil deformity iil~d rapid woight gi~in may c i~ t~sc  :III cbxnggc.ratcttl psy- 
chologic reaction. In  addit io~~, tllrcc: oC tllc i):itii*~~ts i ~ r  t l ~ c  prcschlrt series 
suffered unilateral or t)ilatc.ral spontantboi~s fractllres of the fc~noral Iiead, 
also apparently as the oo~~scc~t rc~~~ce  of stcroitl tlrcri~l)y. 
Finillly, tlic most ;iliirrni~~g c o ~ ~ s c q t ~ c ~ ~ ~ c c  of stcroitl ~idlnirristration 
has beer1 retardation of body growth in tliose r~nfortur~ate 1)atients who 
require this agent clironically in order to lnainti~in homograft function. 
The dilc~nrnit is ill~striitctl in 1Jig11re 32. Tllc clliltlrcn OII the lcft and 
right 11ad prednisolre t1isco11ti1111c.d uftcr five mo11t11s n~ld  olle yeiir rc- 
spectively, with r i ~ p ~ d  s~rl)sec~t~c~~rt grow l~. I'lrc live-year-old boy in the 
Figure 32. Three children (and their donors) who have survived for 2 to 3 years 
, aft- renal homotransplantation. The recipients on the left and right have not received 
I 
steroid therapy for 241 years and 1 year respectively. Their growth has been normal. 
The child in the middle, who is receiving 7.5 mg. of prednisone per day, has grown 
only sLightly and has other evidence of hypercorticism. 
i middle had both early and late rejection episodes and is still receiving 7.5 mg. per day. His height has remained almost unchanged during the 
two years since transplantation. I t  is possible that he will ultimately be 
a dwarf, with a well functioning kidney. 
Splenectomy and Thyrnectomy 
As reported earlier, all patients in the present study had splenec- 
tomy, and six have had thymectomy either prior to transplantation or 
subseq~ently. '~~ OO. The rationale for and the evidence concerning the 
benefit of these adjuvant procedures have been considered at length in 
the cited publications. At the moment it is not clear whether either addi- 
tional procedure is of value in modifying rejection, although there is 
suggestive evidence that thymectomy may .ultimately prove to be use- 
fUL11. 84. 81 
Table 11. Mortaliq and Suruiual in Pediatric Patients Wllo hheiued 
Renal Hornotrans/.dantation at the Uniuersi~ of Colorado Medical Gnter 
SERIES I 
Total nr~rnber of patients treated 20 rnonths or longer ago: 16 
l'atic~~tr clencl: 4 
Patienu alive ~u, of 11 /24/65; 12 
20-24 months: 4 
2-3 yean: 8 
SERIES 11 
Total nuluber of ~ ~ a t i e ~ r t r  trc;~tcil fro111 3 ! 4  to 9 montiu ago: 6 
P a t i e ~ ~ u  dead: 0 
Paticnu alive as of 11 /24/65: 6 
The  operations were performed from November, 1962, to August, 1965, and are 
divided into an early aud late seria. No pediatric casu were done between March, 1964, 
and February, 1965. 'I'ire long lnoratorium war imposed so that a bc-ttcr view of the long- 
tam coursa could be obtained with the originally treated patients before undertaking 
the care of f ruh  casa. TIie fact that no deaths o r  serious con~plications occumd during 
thh period pmrnpted the raumption of the peiiiatric program at  a clinical level. 
Survival, Renal Function and Rehabilitation 
Because of the differences in duration of follow-up, the cases have 
been class&ed as group I and group 11. Thosc iu group I were all treated 
more than a year and a half ago. Twelve (75 per cent) of these 16 
patients are still alive after 21 to 36 months (Table 11). All have good 
renal function. Three have had steroid therapy discontinued. Only three 
patients are currently receiving as much as 10 mg. of prednisone per 
day (Table 9). In each case function has been stable for at least one 
year. Five of the 12 patients still receive some antihypertensive medica- 
tion for control of blood pressure. The current renal function, steroid 
dose, blood pressure, and need for antihypertensive drugs are listed for 
each case in Table 9. 
The six patients in group I1 were operated on from 3% to nine 
months ago. All are still alive with adequate renal function. Similar data 
are given for each of these cases in Table 9. Social rehabilitation has been 
relatively complete in both groups. 
Pathologic Studies 
The changes in renal homotransplants carly after operation have 
been extensively des~ribed.'~. Of greater interest is tlic appearance of 
the chronically tolerated kidney. Eight of the patients in the presently 
reported series have received biopsies of their homogrufts from 21 to 26 
months after operation. Only one of the biopsies (1.1) .X3) was within 
normal limits. Seven of the other specimens showed vasc~~lur lesions and 
cellular infiltration; two in addition showed thickening of the glomerular 
capillary basement membranes. 
In all the kidneys with vessel changes the i~lterlobular arteries were 
narrowed by fibrous intimal thickening ( 1 4 7 s .  XI) ,  ;L process which had 
Figure 33. Biopsy cd renal homograft from patient LD 1 at 2 years. Tlrere is 
intimal thickenuig of an interlobular artery. Adjacent tubules are lined by llutte~led 
atropliic epithelium. Weigert's elastic. x 350. 
Figure 34. Biopsy ci renal llomograft from patient LD 13 at 1 year 9 months. 
A small area of ischemic tubular atropl~y can be seen, associated with interstitial fibrosis, 
dense infiltration with mmonuclear cells and periglomarular fibrosis. H & E. x 300. 
Figure 35. Biopsy of rerial honlognft from patirrit LD 41 at 1 year 10 months. 
Upper, By light microscopy tlte glornerular capillary I)asell~ent nlcn~lrarre is seen to 
be diffusely thickened as in menilranous glornerulor~rpliritis. H & E. x 350. Lower, 
Electron n~icroscopy of part of one of the glonlerulur cnpillary loops shows that the 
basemer~t ~~tembrnne thickening (btn)  is caused by ~rregulur deposrts of electron-deme 
materinl beneath the endotheliurt~ (en), unlike rnenibrallo~~s glomcrulonephritis, in 
which the deposits are usually on t l ~ c  epitheliitl sicie of tile nlrm1,rune. A few of the 
epithelial f w t  processes ( f p )  are fused (arrows ). cap, Capillary lumen; cp, part of 
epitl~eilul cell. Eyon; Pb stain. x 8,950. 
gone on to complete obliteration of the lu~ncn in several illstances. The 
most severe lesions were present in two cases (LD 22, 41) which had 
experienced a second phase of late rejection. At present it seems probable 
that these obliterative vascular lesio~ls are the legacy of such past epi- 
sodes of acute homograft reaction. Tubular atrophy and interstitial 
fibrosis were present in all the cases with occlusive vascular lesions 
(Fig. 34); secondary hypertension had occurred in several of these 
patients. 
In the two renal homografts with glomerular deposits (LD 1, 41) 
material staining positively with periodic-acid-Schiff reagent was present 
on the tuft capillary basemcnt membranes and between the endothelial 
cells, giving an appearance closely resembling tl~at seen in Ellis type I! 
glomerulonephritis ( diffuse membranous glomerulonephritis ) ( Fig. 35). 
'l'llerc is evide~~cc tllnt this couting s~~l)stu~icc is gil1nlllit glol)nli~l, und it 
may represent deposits of antigen-iiutibody complexes. 
Many of the host cells infiltrating the interstitium were large ly~nplio- 
cytes having a prominent Golgi apparat~~s and pyronil~opliilic cytopli~sln 
containing many free ribosomes (Fig. 36). I'robably these cells are pro- 
ducing antibody against the graft and are evidence of a continuing low- 
grade immunologic attack by the host even between the acute episodes 
rccu)g~iix/.c-d cli~~icc~lly its rcjt1r.tio11. Tho 1l11111l)c.r of srnull 1y111oliocytc.s i111c1 
~ I ~ U S I I I U  cells iu  the i~rlc!rslitii~l i ~ ~ l i l t r i ~ t c !  v;i~.it-tl. MI IC~~I~) I IU~L 'S  1111~1 fibro- 
blasts were also present. 
Fiylre 30. Elcctrul~ iiilcrograpli of puri  of I~icqtry of rr-ti111 I~ol~royr,tlt fro111 pu- 
t i ~ ~ i ~ t  1.1) 34 ut  1 y t - t ~ r  l l  111o i i t 1~~ .  A I,trgt! l y i ~ i ~ ~ l i ~ ~ i ~ l  ,141. ~ t \c ~ y t o ~ ~ l ~ t ~ ~ ~ t  (1111 o f  f r w  r11)o- 
WIIIC>, 1 1 ~ 5  111 tile t~itt~r>tltiiirn. tu, Purt ul pmxtn1u1 i t i l ~ ~ i l t : ;  ~ J I I I ,  ttiI11111ir I ~ I A W I I I C I ~ ~  IIICIII- 
braue; 11, uuclcus ot lyn~pho~d ccll; m, ~t~~tocl~o~irlrlo~~. Spun; AJb st.~llt. x 10,000. 
Figure 37. Hiupsy of r c t ~ u l  horrronri~ft fro111 patient LD 41 at 1 year 10 months. 
The j u x t n g l u ~ ~ ~ c r ~ ~ l a r  i tpo i~r i~ tus (arrow) is 11yprrl)lit.rtic.. TIlvrc is t l ~ i c k e l ~ i l ~ g  of the 
plomcn~lar ci~li l l l irry ~~IS~IIIC.II~ ~ ~ ~ c ~ ~ t l ) r ; u ~ c s  i t ~ l c l  4111 trdl~csioc~ I ~ c t w e c t ~  uft  arltl Bowr~~un's 
capslllc. I~,terst i t i i~l  fi )ro.ris a d  t l r l t ~ l i ~ r  i~troplty itre prcsc.I~t uro1111t1 tlte ylall~cnllus. I 1  & 
E. X 300. 
Table 12. . $ i l r ~ ~ ~ r ~ u r v  of lltr f ' , j t / ~ o f ( ~ q ~ i ,  piri(ft~iqs 111 /hc X //ortlrt,qrg/l~ 
f l i o / ~ s ~ r d  , / IOI I I  21 10 20 . \ l o r ~ t / ~ s  .If k r  /?en111 ~ ~ ~ I I I I I ~ ~ ~ U ~ L . ~ ~ I ~ U I I ~ U ~ I ~ I ~  
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Hyperplasia of the juxtaglomen~lar apparatus was present in six of 
the eight transplants (LD 13, 17, 22, 33, 34, 41) (Fig. 37). It was not 
necessarily associatecl with arterial narrowing or hypertension. Since 
il similar change is found ill renal autografts and isografts, it is possi1)ly 
concerned with the maintenance of normal production of renin and per- 
haps erythropoietin. 
A summary of pathologic findings in these eight kidneys is recorded 
in Tal~le 12. 
LIVER TRANSPLANTATION 
In view of the encouraging results after renal homotransplantation, it 
has been natural to think of extending comparable replacement therapy 
to diseases which result in functional failure of other organs. At present, 
liver transplantation appears to offer the most immediate possi1)ility of 
I clinical utility. 
I Orthotopic Liver Transplantation 
Such hope derives principally from studies in dogs. The most in- 
cisive experiments have involved orthotopic transplantation in which the 
recipient animal's own liver is excised ilnd replaced with a homograft 
obtained from an unrelated mongrel i~ilirnal:'~. Y6. Y". "- 61+ 68 with a 
techniqr~e similar to that depicted in Figure 38. With this preparation 
there is no equivocatio~l about the presence or absence of transplant 
viability, since survival provides i~ico~ltrovertible proof of continuous 
homograft function. 
The im~nedinte operative mortality rate l ~ f  orthotopic liver trans- 
plantation in the dog is 10 per cent or less, and the incidence of long- 
term success is comparable to that attainable after homotransplantation 
of the dog kidneyqnn With Iwth organs the severity of the subsequent 
rejection is highly variable in individual experiments, a finding undoubt- 
edly explained by differences in the quality of chance histocompatibility 
matching as discussed earlier. In a recently reported series of nearly a 
hundred canine liver homotransplantations in which azathioprine alone 
was given for immunosuppression, approximately 20 per cent of the 
recipient animals had no cli~lical evidence of rejectiori (Fig. 39); the 
histologic injury to these hornoyrafts was minimal. At the other entl of 
tile spectrum, about one third of the dogs had some delay in the onset of 
rejection, but death d r ~ e  to ho~nograft malfunction occurred after one to 
six weeks. Finally, lialf of the dogs had vitrying manifestations of earlv 
rejectior~, but with eve~ltual partial or evcn relatively complete reversal 
of the consequent biochemical abrlormalities (Fig. 40); in these nninlals 
Figure 38. Co~iiplettd l i u ~ ~ i a n  orthotopic liver hoiirogrilft. Note t l~at  all struch~res 
. 
entcrit~g utrd lcirvirig tlrc! liver nre rnunstn~ctccl il l  n t r t ~ r ~ r l i t l  ali;rto~~iic rnurllicr. (By 
penlrissio~i of Anrr. New York Acad. Sc., 120:739, 1'964.) 
immunosuppressive therapy was not intensified during the rejection 
episode. 'Illis consisterrt fiiidirlg emphasizes the important principle that 
imrnrrriologic rejcctiori tc.nds to bc s1)orit;~ricortsly remittent. 
Recently the elFects of rcvcrsiblc rc!jcction upon Iatc liepatic f~lnc- 
tion and structure have been extensively nnnlyzed.s8 I t  seems probable 
that all homografts, even tl~osc in which function is not demonstrably 
impniretl, undergo ciirly irlvasio~i Iby pyrortirtophilic rno~~onuclenr cells, 
the maximum infiltration rrsuully I~eirig 1)etwcen tile first arid third weeks. 
After this time tlie predomirlant histologic featrrres in most liornografts 
were those of repair and reyenemtio~r, with either :~l)ser~t or relatively 
minor degrees of continuing destruction. Sil~ce tire tnai~t rejection dunage 
was centxizonal, the healing was rnost promirlerrt in these areas with 
interconnecting fibrosis ;trourid the ccrrtral veins, ccr~trilobular bile 
canalicrilar dilatatiori and cholestusis, and ~)ser~tlolol)t~le formation. In 
some of the Ilomogrufts, irrcrc*;lsc.d cotrt~cctivc: tissttc was also present in 
the portal tracts (Fig. 41, upper), but in others, iticluding the longest 
survivor, there were rro rcsiduul abi~ormulities wliatcvc~r ( Fig. 41, lower). 
As after human rcrlitl tr;~nsl)liit~ti~tiotl, tl c I I ~ C C I  for i ~ n ~ ~ i ~ ~ n ~ s i i p p r e s -  
sive therapy has seemed to l ~ e  ditnir~islicd in dogs \\,it11 cl~ronically func- 
tioning orthotopic liver liornografts. T l ~ e  four lo~tyest surviving dogs in 
our Iaboratory after hepatic transplantntion had azathioprine discon- 
tinued after 17 weeks and are still alive, now 12 to 20 months post- 
operatively (Fig. 42). In five other dogs, however, cessation of therapy 
was followed by indolent and progressive late rejection which either led 
to death or necessitated resumption of daily administratiorl of aza- 
thioprine. 
Despite the demonstration that orthotopic transplantatioi~ does not 
present insurmountable problems, this method has not been successfully 
applied for the treatment of patients. To date seven attempts have been ! 
made at human orthotopic transplantation, five in Den~er , "~ .  one in 
Bostonab and one in Paris." Six of these patients had primary malignancy 
or metastasis in their own livers, and the seventh was a child with biliary 
atresia; two died during or immediately after opera ti or^. The other five 
lived for six, seven, 12, !E and 23 days. Experience with these cases has 
delineated certain spechc problems which wlil have to be dealt with 
in future trials. 
Figure 41. Histologic appearance of chronically tolerated orthotopic liver homo- 
grafts. Upper, Biopsy after 123 days. There is some increase in portal connective tiuue. 
proliferation of small biliary ductules, and a slight cellular infiltratiori. This animal 
then had azathioprine therapy discontinued, with subsequent survival for 7 months. 
The dog ultimately died of a perforated duodenal ulcer. Lower, Biopsy of a histo- 
logically normal orthotopic homograft after 302 days' residence in the host. At t l ~ e  tune 
of biopsy the animal had not received irnmunosi~ppressive therapy for 6 months. The 
dog is still alive more than 20 months after operation: The clinical course is depicted 
in Figure 39. H & E. X 40. 
First, the degree of anoxic injury to the cadaveric livers used was 
moderately severe in all instances, evidenced by abrupt increases in 
SGOT and SCPT and bilirubin immediately or early after operation. 
Fortunately, this acute anoxic injury proved to be reversible in all but 
one of the Colorado cases, but the less than ideal circumstances of tissue 
procurement and preservation will continue to be a serious handicap. 
Secondly, the technical problems with orthotopic transplantation in 
the human patient exceed those of most other kinds of surgery. The 
presence of widespread hepatic malignancy (Fig. 43) makes removal 
of the bulky livers difficult. Moreover, most such patients have portal 
hypertension. In addition, the need for ~nultiple vascular anastomosis 
(Fig. 38) and for establisl~rnent of internal biliary draitiage further com- 
pounds the risk. 
Finally, cha~~ges  in tllc! coagulation mechn~iis~n have proved to be 
of tlic utmost irnportunce. h~ost  patic~hts wit11 terminal liver disease enter 
surgery with impairetI clotting. During ~nan i~)u la t io~~  of the liver and 
especially during the a~lhepatic phase o f  the actl~irl tra~rsplantation, acute 
fibri~iolysis is cl~aracteristic.~Vn order to preve~tt bleeding at this critical 
time, tlie first four patients in the Denver series were given epsilon 
ami~~ocaproic a id ( E A C A ) ,  human fibrinogen and fresli blood. 
Ironically, the early thrcitt of fatill hemorrhage is succeeded after 
successful orthotopic transplantation I)y a period of hypercoagulability 
beginning within a few bours after ope~ation."~ Three of our patients had 
peripheral venous throml>osis, apparently at this phase of convales- 
cence,"" Gus with the subsequent development of multiple pulmonary 
eml,oli. Evidently a natural rel>ound hypercoirgul;ibility was exaggeratetl 
in these cases by the clot-promoting agents administered during opera- 
tion. In future trials iatrogenic manil>ulation of the coagulation process 
seems contraindicated. 
Pathologic studies of the homografts froin tllese unsiiccessfully 
treated patients Iiave not diminished the hope that such operations may 
ultimately prove to be feasible. 111 tlie Denver series tlie four patients 
Figure 43. Uulkv I~cputori~a removed fri1111 n P'J-yeur-old worrrtrr~ who received lrrr 
ortl~otopic liver tr;ll)sl)lul~t. 0111~ a rrln of t~orlllul liver tisbue relr~eills. 'rhe pulient sur- 
vrvcd for 23 dirys after the transplant. 
Figure 41. Orthotopic IIIIIII~III  I C I ) U ~ ~ C  11011iogruft at 22 ( I i i y~ .  There is good 
prescrvtrtiaii of liver cells iuld lol)uli~r structllre. The portit] triti4 ( ) ) I  ) c o l ~ t i t i ~ r ~  i~ few 
infiltrating rno~~onuclenr cells. cv, Central vein. 11 & E. X 90. 
who survivc.tl ol)c*ratio~~ alid received tlie sillnc gc.neriil i~nml~nosup- 
pressive regirrlcl~ usc!d for kirllieys it11 liatl rclativc4y good preservation 
of liver architecti~re (Fig. 44) .  Mo~~onuclear cell invasion was relatively 
~ninimal, i111d the clegree of Ilepirtocyte loss alld reticulin coldensation 
seerned less tllitn in allimu1.v itt ;I cornpri11)le stage of co~)vaIescence."* 
1)ciitll rcsl~ltcrl fro111 l'uctors otlicr tlian crrislii~rg rcjcctio~~, as discussed in 
cletail c.lsewl~cre.~~ 
Auxiliury Liver Trunsplul~tution 
At  first thor~gl~t i~r~xiliiiry lrcl~iitic t r i~~rs~) l i t~~t i r t io~~,  i l l  wllidr the pa- 
tict~rt's residual Iivctr t i s s~~e  is 11ot rcrnovc.d, wo111tl see111 to Iliive important 
advailtirges for tlie treatment of I)eiiign diseases s11cl1 as congenital biliary 
atresia or Laennec's cirrllosis. With thc~se tech~iiqurs, first drscril~ed by 
Welch,ll- U7 the Iio~~~ogriift is l)lact.d in a Ileterotopic positio~i such as 
the pelvis (Fig. 45, A )  or left upper portion of the abdomen. It has 
recently been demonstriitcd that the metliod of vc~iotis revascr~larjzatio~i 
ot stlclr a Iio~liognitt is of pitriuno~~nt i~liportiulcc: i l l  determining its 
sul,seclnent fate, at least i r t  a~lirnais. 
With Welcli's preparation, in wliicli tile pt.lvic homograft received 
its vchnolls illflow trom the tc.rnli11i11 iufcrior vc8nit cbavil, ;I rrmurkable 
iitropllv ot t i i t .  it~~xilii~ry 1ivc.r \viis 11otc~1 i l l clogs trc.iiteJ with iixirthioprine, 
usualiy I ) ~ ~ I I I I I ~ I I L J  \vitliili two we~ks . "~ .  GU SuLscclucl~t studies have ex- 
plained this phenornen~n.~~. 20 If the portal supply of the extxa liver 
was derived from the splanchnic venous system (Fig. 45, B) ,  the homo- 
grafted liver did not atrophy, and instead there was symmetrical shrink- 
age of the host liver. These findings indicate that there can be a 
competitive relation between coexistent livers. In dogs the organ which 
is perfused with venous return from the splanchnic bed operates at a 
physiologic advantage. If neither liver is provided with direct splanchnic 
venous blood flow, as illustrated in Figure 46, the hepatic tissue which 
receives the greatest total blood is favored, but the degree of preserva- 
tion is less complete than with ideal vascularization.l2. 'H 
In the human patient with terminal benign liver disease, the role of 
the foregoing factor of substrate competition is not known. The diseased 
liver in such patients has lost much of its capacity for competition, and, 
in addition, the portal contribution to total hepatic flow is apt to be 
greatly reduced. For these reasons and because provision of splanchnic 
flow for the auxiliary homograft is mechanically difficult, two patients 
Figure 45. Experimental auxiliary homotranspiantation of the liver. A. Welch's 
origmal operation. Note that the portal venous i d o w  is derived from the terminal 
vena cava and that the hepatic arterial supply is from the iliac artery. The auxiliary 
liver undergoes rapid atrophy beginning within 2 weeks after operation. B. Modifica- 
tion of auxiliary homotransplantation in which the homograft portal vein is revascu- 
larized from the distal splanchnic venous system. Retrograde splanchnic venous flow 
through the homograft is promoted by prox~mal ligation of the recipient portal vein. 
With this method of revascularizcltion the homograft atrophy is avoided; instead, d ~ e  
recipient's own liver shnnks. ( By pernilsslun of Surg., Cynec. G OLst.. 121 : 17. 1965 1. 
Figure 46. Method of uuxiliury liver rmr~splantation wliich 11ns received a clini- 
cal trial. The procedure has been used twice at  the University of Colorado Medical 
Center in patients with terminal Laennec's cirrhosis. A, B, First-stage portacaval anas- 
tomosis is performed. This will usually be necessary for wntrol of variceal hemorrhage. 
C, Revascularization of t l ~ e  auxiliary liver in the right paravertebral gutter. 
treated in Denver received the compromise procedure depicted in Figure 
48. l'rcli~ninary portacavul anastomoses were performed four days and 
one day before the transplantation, respectively. Laennec's cirrhosis was 
the underlying disease. - 
- 
In both cases the auxiliary livers functioned immediately, but the 
improvement in liver chemistries secondarily deteriorated from seven to 
10 duys later (Figs. 47, 48). The patients died of septic complications 
at 22 and 34 days, before there was evidence of reversal of the clinically 
diagnosed rejections. The first patient had staphylococcal pneumonia, 
and the second had Pneumocystis curinii, cytomegalic virus inclusion 
disease U I I ~  hemorrhagic nionilial enterocolitis. 
Pathologic studies of these two auxiliary homografts produced evi- 
dence of active rejection in the patient who survived for 22 days. The 
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Figure 47. Clinical coune of a patient with Laennec's cirrhosis who received UII 
aurikary liver homograft. The preliminary portacaval shunt controlled massive hemor- 
rhage from esophageal varices. Note the evidence of function of the transplanted liver 
with a fall in the serum bilirubin nnd a sustained improvement in the prothrumbin 
time. The bilirubin had begun to rise secondarily at the time of death from septic com- 
plications. The donor was a 77-year-old man who died of a cardiac arrest. Both were 
.4 + blood type. 
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Figure 48. Clinical course tlfter hurnurl auxilii~ry liver trnnsplilntation. The pre- 
liminary portocavul shunt was d o ~ l e  1 day before the trunspli~nt. 'l'he donor was a 12- 
year-old boy who was killed in an automobile accident. The homograft elaborated bile 
within a few minutes after its revascc~lnrization. There was late deterioration of homo- 
graft function, but the pri~iiary cause of death was repsis. 
portal tracts were infiltrated with mononuclear cells, between 5 and 10 
per cent of which were large lymphocytes with pyroninophilic cytopkm 
(Fig. 49). There were also foci of fibrinoid necrosis in the walls oi sev- 
eral of the smaller branches of the hepatic artery. Absence of infilbang 
cells and lack of vascular damage made it difficult to believe that acute 
rejection was occurring terminally in the second, longer-lived hepatic 
homograft. This liver at  34 days did, however, show necrosis of the 
centrilobular hepatocytes, accompanied by collapse and condensaclon 
of the centrizonal reticulin (Fig. 50). Cytomegalic virus inclusions were 
present in the biliary epithelial cells (Fig. 51). It is tempting to t h k  
that this centrizonaI damage had occurred at the time of rejection a d  
was in the process of being repaired when the patient died from idec- 
tion by opportunistic organisms. Centrilobular cholestasis with bile 
"thrombi" was a prominent feature of both hepatic homografts. 
In a third case an attempt at auxiliary homotransplantation to a 15- 
month-old child with biliary atresia failed immediately because of tech- 
nical complications. Other trials have been made by Absolon,' Herrnann,"J 
Hume10 and Gliedman,O all resulting in early death. In several of these 
cases, difficulty was encountered in closing the abdomen, owing to the 
mass of the extra organ. Predictions about the future usefulness of the 
auxiliary operations should be held in abeyance for the moment in \;ew 
of these mechanical problems, because of the unknown influence of the 
physiologic factors alluded to above, and because ani,mal results with 
auxiliary transplantation have not been as promising as with the o d o -  
topic operation. 
Flgure 49. Auxiliary human hepatic homograft at 22 days. Hlgh-power \:cw 
of a portal tract which is densely diltr'llted with mononuclear ceUs. H & E. x 600. 
. --- - ---. - -  
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Figure 50. Auxiliary human hepatic homograft at 34 days. There is necrosis of 
the centrilobulnr Ilepatocytes and fat droplets in the midzonal and peripheral liver &. cv, Central vein; pt, portal tract. H & E. x 80. 
Figure 51. Intranuclear inclus~on ( arrow ) of cytomegalovirus disuse d t L o g  
an ep~thelial cell Uning a small biliar~ duct m the human a d a r y  hepatic homograft 
rho- in Figure 50. H & E. x 800. 
THE ROLE OF ORGAN TRANSPLANTATION IN PJCDLATRIOI 
I 
1 SUMMARY 
I 
i Experience has been recounted with 22 patients treated with renal 
homotransplantation at or before the age of 18 years. Eighteen of the 
I 22 patients are still alive from 3% months to three years after operation. 
Twelve are alive at least 21 months postoperatively; eight of the 12 are 
two to three years. The unique technical, medical and sociologic prob- 
lems encountered in treating patients of this age group are described. 
I Biopsies of eight of the homografts from 21 to 26 months after operation 
i revealed that only one of the kidneys was normal. The others showed 
narrowing of the interlobular arteries by fibrous intimal thickening and 
I 
interstitial infiltration by large lymphoid cells. In two of the homografts 
there was also thickening of the glomerular capillary basement mem- 
branes, giving an appearance resembling diffuse membranous glomeru- 
lonephritis. Juxtaglomemlar hyperplasia was present in six of the eight 
homografts. 
Progress in the field of liver transplantation is also cited. The prin- 
cipal encouraging developments have been in animal experimentation. 
Although long-term survival in human subjects has not yet been 
achieved, dogs with orthotopic liver transplantation have been living 
I in good health for as long as 20 months. Advances have also been made - 
bearing upon auxiliary liver transplantation, an operation which does 
not involve removal of the patient's own liver. Although preservation of 
the patient's liver would seem to be advantageous for several reasons, 
there are also serious and fundamental disadvantages to this approach 
which may limit its usefulness. 
ADDENDUM 
Since submission of this manuscript, two additional patients with 
renal homotransplantation have died. The first patient (LD 79), who 
had poor function at the time of the original report, died of a fungal 
sepsis of the brain and lungs (AspergiUus fumigatus). There was exten- 
sive histologic injury to the homograft, Survival was 254 days. 
The second patient (LD 80) died of systemic histoplasmosis. There 
was almost no evidence of rejection injury to his kidney. Survival was 
295 days. 
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